Terms: = Liver cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
327 results:
1. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.
Yang Y; Wang H; Si J; Zhang L; Ding H; Wang F; He L; Chen X
J Cancer Res Clin Oncol; 2024 Apr; 150(5):223. PubMed ID: 38691204
[TBL] [Abstract] [Full Text] [Related]
2. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution.
Vaghiri S; Prassas D; Mustafov O; Kalmuk S; Knoefel WT; Lehwald-Tywuschik N; Alexander A; Dizdar L
BMC Surg; 2024 Apr; 24(1):101. PubMed ID: 38589847
[TBL] [Abstract] [Full Text] [Related]
3. Colorectal metastases with intrabiliary growth: incidence, treatment, and outcomes.
Langella S; Armentano S; Russolillo N; Luzzi AP; Fontana AP; Daniele L; Ferrero A
Updates Surg; 2024 Apr; 76(2):459-469. PubMed ID: 38483785
[TBL] [Abstract] [Full Text] [Related]
4. Molecular pathological approach to cancer epigenomics and its clinical application.
Kanai Y
Pathol Int; 2024 Apr; 74(4):167-186. PubMed ID: 38482965
[TBL] [Abstract] [Full Text] [Related]
5. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
Yang Y; Mirzaei G
PLoS One; 2024; 19(2):e0293607. PubMed ID: 38422094
[TBL] [Abstract] [Full Text] [Related]
6. O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
Feng Z; Yin J; Zhang Z; Chen Z; Huang L; Tang N; Wang K
Oncogene; 2024 Apr; 43(15):1149-1159. PubMed ID: 38396292
[TBL] [Abstract] [Full Text] [Related]
7. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract] [Full Text] [Related]
8. Oxidative Stress Promotes liver cancer Metastasis via RNF25-Mediated E-Cadherin Protein Degradation.
Huang Z; Zhou L; Duan J; Qin S; Jiang J; Chen H; Wang K; Liu R; Yuan M; Tang X; Nice EC; Wei Y; Zhang W; Huang C
Adv Sci (Weinh); 2024 Apr; 11(13):e2306929. PubMed ID: 38286671
[TBL] [Abstract] [Full Text] [Related]
9. Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
Kato Y; Fukazawa T; Tanimoto K; Kanawa M; Kojima M; Saeki I; Kurihara S; Touge R; Hirohashi N; Okada S; Hiyama E
Cancer Sci; 2024 Mar; 115(3):847-858. PubMed ID: 38183173
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
Chen MF; Ho MC; Kao JH; Hwang RM; Deng SB; Yen KC; Liang PC; Wu CH
J Formos Med Assoc; 2024 Mar; 123(3):318-324. PubMed ID: 38044205
[TBL] [Abstract] [Full Text] [Related]
11. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
Meng Z; Li P; Yang D; Huang H; Dong H; Qin Y; Bin Y; Li R; Wang S; Chen X; Kang M
Radiother Oncol; 2024 Feb; 191():110027. PubMed ID: 38008418
[TBL] [Abstract] [Full Text] [Related]
12. Refining MRI-based criteria for portal vein invasion in hepatocellular carcinoma: improving sensitivity beyond portal vein tumor thrombosis.
Kim J; Jeong WK; Kim JM; Ha SY; Kim K
Abdom Radiol (NY); 2024 Feb; 49(2):437-446. PubMed ID: 37989897
[TBL] [Abstract] [Full Text] [Related]
13. Mitigating SUV uncertainties using total body PET imaging.
Smith CLC; Zwezerijnen GJC; den Hollander ME; Weijland J; Yaqub M; Boellaard R
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1070-1078. PubMed ID: 37953391
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M
Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079
[TBL] [Abstract] [Full Text] [Related]
16. Ranitidine Use and Incident cancer in a Multinational Cohort.
You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
[TBL] [Abstract] [Full Text] [Related]
17. LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm.
Jeong B; Choi SJ; Choi SH; Jang HJ; Byun JH; Won HJ; Shin YM
Eur Radiol; 2024 Feb; 34(2):1210-1218. PubMed ID: 37589898
[TBL] [Abstract] [Full Text] [Related]
18. Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells.
Sanchez-Martin A; Sanchon-Sanchez P; Romero MR; Marin JJG; Briz O
Biomed Pharmacother; 2023 Sep; 165():115209. PubMed ID: 37499450
[TBL] [Abstract] [Full Text] [Related]
19. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
Yu X; Yang R; He Z; Li K; Zeng P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
[TBL] [Abstract] [Full Text] [Related]
20. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract] [Full Text] [Related]
[Next]
